Literature DB >> 30210970

Impact of Surgical Margin in Skull Base Surgery for Head and Neck Sarcomas.

Kenya Kobayashi1, Fumihiko Matsumoto1, Yasuji Miyakita2, Taisuke Mori3, Tatsunori Shimoi4, Naoya Murakami5, Akihiko Yoshida3, Ayumu Arakawa6, Go Omura1, Masahiko Fukasawa1, Yoshifumi Matsumoto1, Satoko Matsumura1, Jun Itami5, Yoshitaka Narita2, Seiichi Yoshimoto1.   

Abstract

Objective  This study aimed to determine the adequate resection margin in skull base surgery for head and neck sarcoma. Design  We retrospectively reviewed 22 sarcomas with skull base invasion. Induction chemotherapy, followed by surgery and postoperative radiotherapy and adjuvant chemotherapy, was performed in 18 patients with chemosensitive sarcomas, and surgery with or without postoperative radiotherapy was performed in four patients with chemoresistant sarcomas. Radical resection was performed in patients with chemosensitive sarcomas with a poor response to induction chemotherapy and in patients with chemoresistant sarcomas. Conservative resection with close surgical margin was performed in patients with chemosensitive sarcomas with a good response to induction chemotherapy. Setting and Participants  This single-centered retrospective study included patients from the National Cancer Center Hospital, Japan. Results  The response to induction chemotherapy was significantly associated with the 3-year local control rate (LCR; good response versus poor response: 100% versus 63%, p  = 0.048). Patients with a good response to chemotherapy had a favorable local prognosis even when the local therapy was conservative resection. In radical skull base surgery, patients whose surgical margins were classified as "wide margin positive" had significantly poorer 3-year LCR than did patients with "margin negative" or "micro margin positive" margins (25% versus 83%, p  = 0.014). Conclusion  Conservative resection with close surgical margins might be acceptable for chemosensitive sarcomas with a good response to chemotherapy. Resection margin status was an important predictive factor for local recurrence after radical skull base surgery. Microscopic microresidual tumor might be controlled by postoperative treatment.

Entities:  

Keywords:  chemosensitivity; head and neck sarcoma; induction chemotherapy; skull base surgery; surgical margin

Year:  2018        PMID: 30210970      PMCID: PMC6133685          DOI: 10.1055/s-0037-1615816

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  11 in total

Review 1.  Distinctive soft tissue tumors of the head and neck.

Authors:  Christopher D M Fletcher
Journal:  Mod Pathol       Date:  2002-03       Impact factor: 7.842

Review 2.  Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies.

Authors:  Suman Malempati; Douglas S Hawkins
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

3.  The approaches and outcomes of skull base surgery for pediatric sarcoma after initial therapy.

Authors:  Kazuchika Ohno; Atsunobu Tsunoda; Satoshi Shirakura; Naoto Takahashi; Seiji Kishimoto
Journal:  Auris Nasus Larynx       Date:  2010-11-04       Impact factor: 1.863

4.  Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.

Authors:  W M Crist; J R Anderson; J L Meza; C Fryer; R B Raney; F B Ruymann; J Breneman; S J Qualman; E Wiener; M Wharam; T Lobe; B Webber; H M Maurer; S S Donaldson
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

5.  The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.

Authors:  Aaron C Spalding; Douglas S Hawkins; Sarah S Donaldson; James R Anderson; Elizabeth Lyden; Fran Laurie; Suzanne L Wolden; Carola A S Arndt; Jeff M Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-01       Impact factor: 7.038

6.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

7.  Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.

Authors:  Carola A S Arndt; Julie A Stoner; Douglas S Hawkins; David A Rodeberg; Andrea A Hayes-Jordan; Charles N Paidas; David M Parham; Lisa A Teot; Moody D Wharam; John C Breneman; Sarah S Donaldson; James R Anderson; William H Meyer
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Long-term outcome following radical temporal bone resection for lateral skull base malignancies: a neurosurgical perspective.

Authors:  Nobutaka Kawahara; Tomio Sasaki; Takahiro Asakage; Kazunari Nakao; Masashi Sugasawa; Hirotaka Asato; Isao Koshima; Nobuhito Saito
Journal:  J Neurosurg       Date:  2008-03       Impact factor: 5.115

9.  Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience.

Authors:  Brandon G Bentz; Mark H Bilsky; Jatin P Shah; Dennis Kraus
Journal:  Head Neck       Date:  2003-07       Impact factor: 3.147

10.  Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma.

Authors:  Kenya Kobayashi; Fumihiko Matsumoto; Makoto Kodaira; Taisuke Mori; Naoya Murakami; Akihiko Yoshida; Daisuke Maki; Masanori Teshima; Masahiko Fukasawa; Jun Itami; Masahiro Asai; Seiichi Yoshimoto
Journal:  Cancer Med       Date:  2016-08-26       Impact factor: 4.452

View more
  2 in total

1.  Roles of skull base surgery and particle radiotherapy for orbital malignant tumors involving the skull base.

Authors:  Masanori Teshima; Hirotaka Shinomiya; Hidehito Kimura; Kazunobu Hashikawa; Naomi Kiyota; Daisuke Miyawaki; Ryohei Sasaki; Eiji Kohmura; Ken-Ichi Nibu
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-10-28

2.  Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series.

Authors:  Ahmed Habib; Idara Edem; Diana Bell; Shirley Y Su; Ehab Y Hanna; Michael E Kupferman; Franco DeMonte; Shaan M Raza
Journal:  Curr Oncol       Date:  2022-09-14       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.